Influence of preoperative anti-cancer therapy on resectability and perioperative outcomes in patients with pancreatic cancer: Project study by the Japanese Society of Hepato-Biliary-Pancreatic Surgery

A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907)

(2011) Nobutoshi Ando et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant/Preoperative Gemcitabine for Patients with Localized Pancreatic Cancer: A Meta-analysis of Prospective Studies

(2011) Angelo Andriulli et al.   ANNALS OF SURGICAL ONCOLOGY

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study)

(2011) Stefan Heinrich et al.   BMC CANCER

Neo-adjuvant Chemoradiation Therapy Using S-1 Followed by Surgical Resection in Patients with Pancreatic Cancer

(2011) Sohei Satoi et al.   JOURNAL OF GASTROINTESTINAL SURGERY

A Systematic Review and Meta-analysis of Survival and Surgical Outcomes Following Neoadjuvant Chemoradiotherapy for Pancreatic Cancer

(2011) Jerome Martin Laurence et al.   JOURNAL OF GASTROINTESTINAL SURGERY

Retrospective Evaluation of the Influence of Postoperative Tumor Marker Status on Survival and Patterns of Recurrence After Surgery for Pancreatic Cancer Based on RECIST Guidelines

(2010) Fuyuhiko Motoi et al.   ANNALS OF SURGICAL ONCOLOGY

Locoregional treatment of primary breast cancer

(2010) Manfred Kaufmann et al.   CANCER

Neoadjuvant therapy is associated with improved survival in resectable pancreatic adenocarcinoma

(2010) Avo Artinyan et al.   CANCER

Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection

(2010) John P. Neoptolemos et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Neoadjuvant treatment for resectable pancreatic cancer: Time for phase III testing?

(2010) Michele Reni   WORLD JOURNAL OF GASTROENTEROLOGY

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review

(2009) R. Le Scodan et al.   ANNALS OF ONCOLOGY

Feasibility and Efficacy of Combination Therapy With Preoperative Full-Dose Gemcitabine, Concurrent Three-Dimensional Conformal Radiation, Surgery, and Postoperative Liver Perfusion Chemotherapy for T3-Pancreatic Cancer

(2009) Hiroaki Ohigashi et al.   ANNALS OF SURGERY

A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer

(2009) H Ueno et al.   BRITISH JOURNAL OF CANCER

Neoadjuvant Radiation Is Associated With Improved Survival in Patients With Resectable Pancreatic Cancer: An Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Registry

(2008) Alexander M. Stessin et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Gauri R. Varadhachary et al.   JOURNAL OF CLINICAL ONCOLOGY

Prospective Phase II Trial of Neoadjuvant Chemotherapy With Gemcitabine and Cisplatin for Resectable Adenocarcinoma of the Pancreatic Head

(2008) Stefan Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Preoperative Gemcitabine-Based Chemoradiation for Patients With Resectable Adenocarcinoma of the Pancreatic Head

(2008) Douglas B. Evans et al.   JOURNAL OF CLINICAL ONCOLOGY